IMMUTIL-S 360

About

IMMUTIL-S 360 contains Mycophenolate Mofetil, an immunosuppressant medication used to prevent organ rejection in patients who have received kidney, heart, or liver transplants. It acts as a selective, non-competitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for the de novo synthesis of guanosine nucleotides. This inhibition primarily affects lymphocytes, which are highly dependent on this pathway for proliferation, while other cell types can utilize salvage pathways.

By selectively inhibiting lymphocyte proliferation and function, Mycophenolate Mofetil effectively suppresses the immune response responsible for attacking the transplanted organ. It is often used in combination with other immunosuppressants, such as calcineurin inhibitors and corticosteroids, to achieve optimal immunosuppression and minimize the risk of acute rejection episodes. Careful monitoring of blood counts and gastrointestinal symptoms is important during therapy.

Uses

• Prophylaxis of organ rejection in kidney transplant recipients.
• Prophylaxis of organ rejection in heart transplant recipients.
• Prophylaxis of organ rejection in liver transplant recipients.
• Treatment of refractory rejection in some transplant settings.

Directions For Use

Take orally, usually twice daily, preferably on an empty stomach for optimal absorption. Follow your doctor's instructions precisely.

Benefits

• Effective in preventing acute organ transplant rejection.
• Often used as part of a multi-drug immunosuppressive regimen.
• Reduces the need for high-dose corticosteroids.
• Improves long-term graft survival.
• Well-established safety and efficacy profile.
• Available in various strengths for flexible dosing.

Side Effects

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Leukopenia (low white blood cell count)
• Anemia (low red blood cell count)
• Thrombocytopenia (low platelet count)
• Increased risk of infection
• Increased risk of malignancy (lymphoma, skin cancer)
• Hypertension (high blood pressure)
• Headache
• Tremor
• Abdominal pain
• Dyspepsia
• Hepatitis (liver inflammation)

Safety Measures

• Alcohol - No specific direct interaction, but general caution is advised with immunosuppressants. Avoid excessive alcohol consumption.
• Pregnancy - Highly teratogenic and contraindicated during pregnancy. Women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended. Mycophenolate Mofetil is excreted into breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution in patients with severe liver impairment; dose adjustment may be necessary.
• Kidney - Dose adjustment may be needed in patients with severe chronic renal impairment. Monitor renal function regularly.
• Lung - Rarely, Mycophenolate Mofetil can cause interstitial lung disease or pulmonary fibrosis. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.